Pollara Justin, McGuire Erin, Fouda Genevieve G, Rountree Wes, Eudailey Josh, Overman R Glenn, Seaton Kelly E, Deal Aaron, Edwards R Whitney, Tegha Gerald, Kamwendo Deborah, Kumwenda Jacob, Nelson Julie A E, Liao Hua-Xin, Brinkley Christie, Denny Thomas N, Ochsenbauer Christina, Ellington Sascha, King Caroline C, Jamieson Denise J, van der Horst Charles, Kourtis Athena P, Tomaras Georgia D, Ferrari Guido, Permar Sallie R
Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.
J Virol. 2015 Oct;89(19):9952-61. doi: 10.1128/JVI.01560-15. Epub 2015 Jul 22.
Infants born to HIV-1-infected mothers in resource-limited areas where replacement feeding is unsafe and impractical are repeatedly exposed to HIV-1 throughout breastfeeding. Despite this, the majority of infants do not contract HIV-1 postnatally, even in the absence of maternal antiretroviral therapy. This suggests that immune factors in breast milk of HIV-1-infected mothers help to limit vertical transmission. We compared the HIV-1 envelope-specific breast milk and plasma antibody responses of clade C HIV-1-infected postnatally transmitting and nontransmitting mothers in the control arm of the Malawi-based Breastfeeding Antiretrovirals and Nutrition Study using multivariable logistic regression modeling. We found no association between milk or plasma neutralization activity, antibody-dependent cell-mediated cytotoxicity, or HIV-1 envelope-specific IgG responses and postnatal transmission risk. While the envelope-specific breast milk and plasma IgA responses also did not reach significance in predicting postnatal transmission risk in the primary model after correction for multiple comparisons, subsequent exploratory analysis using two distinct assay methodologies demonstrated that the magnitudes of breast milk total and secretory IgA responses against a consensus HIV-1 envelope gp140 (B.con env03) were associated with reduced postnatal transmission risk. These results suggest a protective role for mucosal HIV-1 envelope-specific IgA responses in the context of postnatal virus transmission. This finding supports further investigations into the mechanisms by which mucosal IgA reduces risk of HIV-1 transmission via breast milk and into immune interventions aimed at enhancing this response.
Infants born to HIV-1-infected mothers are repeatedly exposed to the virus in breast milk. Remarkably, the transmission rate is low, suggesting that immune factors in the breast milk of HIV-1-infected mothers help to limit transmission. We compared the antibody responses in plasma and breast milk of HIV-1-transmitting and -nontransmitting mothers to identify responses that correlated with reduced risk of postnatal HIV-1 transmission. We found that neither plasma nor breast milk IgG antibody responses were associated with risk of HIV-1 transmission. In contrast, the magnitudes of the breast milk IgA and secretory IgA responses against HIV-1 envelope proteins were associated with reduced risk of postnatal HIV-1 transmission. The results of this study support further investigations of the mechanisms by which mucosal IgA may reduce the risk of HIV-1 transmission via breastfeeding and the development of strategies to enhance milk envelope-specific IgA responses to reduce mother-to-child HIV transmission and promote an HIV-free generation.
在资源有限地区,对于感染HIV-1的母亲所生的婴儿,如果替代喂养不安全且不切实际,那么在整个母乳喂养期间,婴儿会反复接触HIV-1。尽管如此,即使在母亲未接受抗逆转录病毒治疗的情况下,大多数婴儿在出生后也不会感染HIV-1。这表明感染HIV-1的母亲母乳中的免疫因子有助于限制垂直传播。在基于马拉维的母乳喂养抗逆转录病毒药物与营养研究的对照臂中,我们使用多变量逻辑回归模型,比较了产后传播HIV-1的和未传播HIV-1的C亚型HIV-1感染母亲的HIV-1包膜特异性母乳和血浆抗体反应。我们发现,母乳或血浆中和活性、抗体依赖性细胞介导的细胞毒性或HIV-1包膜特异性IgG反应与产后传播风险之间没有关联。虽然在对多重比较进行校正后的主要模型中,包膜特异性母乳和血浆IgA反应在预测产后传播风险方面也未达到显著水平,但随后使用两种不同检测方法进行的探索性分析表明,母乳中针对HIV-1包膜gp140共识序列(B.con env03)的总IgA和分泌型IgA反应强度与降低产后传播风险相关。这些结果表明,粘膜HIV-1包膜特异性IgA反应在产后病毒传播过程中具有保护作用。这一发现支持进一步研究粘膜IgA降低HIV-1通过母乳传播风险的机制,以及旨在增强这种反应的免疫干预措施。
感染HIV-1的母亲所生婴儿会反复接触母乳中的病毒。值得注意的是,传播率很低,这表明感染HIV-1的母亲母乳中的免疫因子有助于限制传播。我们比较了传播HIV-1和未传播HIV-1的母亲血浆和母乳中的抗体反应,以确定与降低产后HIV-1传播风险相关的反应。我们发现,血浆和母乳中的IgG抗体反应均与HIV-1传播风险无关。相反,母乳中针对HIV-1包膜蛋白的IgA和分泌型IgA反应强度与降低产后HIV-1传播风险相关。本研究结果支持进一步研究粘膜IgA降低HIV-1通过母乳喂养传播风险的机制,以及制定策略增强母乳包膜特异性IgA反应,以减少母婴HIV传播,推动实现无HIV一代。